Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Franklin Asian Equity Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseFranklinHDFC
NAV₹40.9618₹22.6640
NAV date19 Nov 202619 Nov 2026
History18.8 years3.1 years
Expense ratio2.5%2.1%
Stars★★★★★★★★★★
Growth Score67.8093.90

Returns

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
1 month−1.89%+12.11%
3 months−8.92%+6.07%
6 months−4.16%+16.75%
YTD+15.22%+31.54%
1 year+19.83%+30.13%
3 years (CAGR)+18.38%+29.02%
5 years (CAGR)+5.85%—
10 years (CAGR)+9.48%—
Since launch+8.06%+30.03%

Risk

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
Volatility17.7%15.7%
Downside volatility10.5%8.6%
Sharpe0.671.44
Sortino1.132.62
Calmar1.261.93
Return / risk1.041.85
Deepest fall−42.78%−15.07%
Days to recover325133
Below its high−12.09%−0.21%

Against benchmark

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
Alpha+9.75%+6.18%
Beta0.520.97
R²22.0%85.3%
Up capture68.4%106.1%
Down capture3.8%74.4%
Tracking error17.4%6.0%
Information ratio0.420.95
Treynor0.230.22

Consistency

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
Best 1-year+73.08%+64.96%
Middle 1-year+10.69%+21.84%
Worst 1-year−34.42%+0.52%
1-year periods with a loss24.7%0.0%
Middle 3-year+9.00%+28.64%
Positive months58.3%69.4%
Best day+5.04%+3.19%
Worst day−6.67%−3.62%
Worst 5% day−1.68%−1.50%
Positive days56.7%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Franklin Asian Equity FundHDFC Pharma and Healthcare Fund
5-year XIRR+14.07%—
5-year value₹8,59,386—
3-year XIRR+18.67%+25.83%
1-year XIRR+3.73%+38.53%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth